This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
2023 Atrial Fibrillation Electrophysiology 
DAIC
DECEMBER 29, 2023
This week, the Cleveland Clinic enrolled the first patient in the AVANT GUARD trial, overseen by Dr. Oussama Wazni, vice chair of cardiovascular medicine and section head, Cardiac Electrophysiology and Pacing, Cleveland Clinic, who is also serving as the lead investigator of the trial. Circulation.
DAIC
FEBRUARY 6, 2024
Getty Images milla1cf Tue, 02/06/2024 - 20:36 February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial ( NCT05883631 ), a study formally launched in late October 2023. The Ablamap System includes a workstation with software and monitor, amplifier, and proprietary basket mapping catheter and cables. "I
104 
Dr. Smith's ECG Blog
MAY 7, 2024
Definitely atrial fibrillation. Probably WPW but is very slow for atrial fib withWPW. So this looks like WPW with Atrial fibrillation. What is unusual is that the rate is not REALLY fast, as you expect when there is atrial fib with an accessory pathway. Goyal et al — StatPearls: July, 2023 ).
Frontiers in Cardiovascular Medicine
FEBRUARY 17, 2025
Backgroundwide antral pulmonary vein isolation (PVI) is effective for treating paroxysmal atrial fibrillation (PAF), although time-demanding. Procedural data and electrophysiology (EP) laboratory times were systematically collected and analyzed.
HeartRhythm
SEPTEMBER 23, 2024
Atrial fibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.
DAIC
FEBRUARY 27, 2024
The first procedures, performed by leading physicians Saibal Kar , MD, FACC, FSCAI, (Program Director, Cardiovascular Disease Fellowship, Los Robles Health System , California, HCA Healthcare National Physician Director, Interventional Cardiology) and Devi Nair , MD, FACC, FHRS, (Director, Cardiac Electrophysiology Division, St.
DAIC
JANUARY 31, 2024
intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. "The
111 
Dr. Smith's ECG Blog
JANUARY 9, 2024
She also has a hx of paroxysmal atrial fibrillation and is on oral anticoagulant treatment. the most commonly overlooked arrhythmia ( See My Comment at the bottom of the page in the May 1, 2023 — and the November 12, 2019 post , among others ). The last echocardiography 12 months ago showed HFmrEF.
119 
Dr. Smith's ECG Blog
DECEMBER 13, 2024
Whenever it is this fast, you need to be very careful to ascertain whether it is irregular ( as in atrial fibrillation with rapid ventricular respsonse ) or regular ( as in VT ). This is not because it is polymorphic VT; it is because it is WPW with atrial fibrillation. 2023, January 31). Smith : What do you think?
103 
Circulation: Arrhythmia and Electrophysiology
NOVEMBER 7, 2023
Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012199, November 1, 2023. BACKGROUND:β-AR (β-adrenergic receptor) stimulation regulates atrial electrophysiology and Ca2+homeostasis via cAMP-dependent mechanisms; however, enhanced β-AR signaling can promote atrial fibrillation (AF).
HeartRhythm
MAY 15, 2024
1 Catheter ablation for atrial fibrillation (AF) and ventricular tachycardia (VT) has become the standard of care for many patients presenting with these arrhythmias.2–4 In the past decade, major advances were made in catheter ablation for arrhythmias and implantation of cardiac implantable electronic devices.1
Journal of Cardiovascular Electrophysiology
OCTOBER 23, 2023
Abstract Atrial fibrillation (AF) is currently defined as symptomatic by asking patients if they are aware of when they are in AF and if they feel better in sinus rhythm. The review is based on a presentation by the senior author during the 2023 16th annual European Cardiac Arrhythmia Society (ECAS) congress in Paris, France.
DAIC
DECEMBER 8, 2023
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).
Circulation: Arrhythmia and Electrophysiology
NOVEMBER 3, 2023
Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012043, November 1, 2023. BACKGROUND:In patients with persistent atrial fibrillation (PersAF), catheter ablation aiming for pulmonary vein isolation (PVI) is associated with moderate clinical effectiveness.
HeartRhythm
NOVEMBER 16, 2024
The international Working Group of the Signal Summit is a consortium of experts in the field of cardiac electrophysiology dedicated to advancing knowledge on understanding and clinical application of signal recording and processing techniques.
Dr. Smith's ECG Blog
FEBRUARY 18, 2024
Many ECG readers will not comment any further on rhythm once ventricular pacing has been identified, but it is still critical to determine the atrial rhythm. In this case, it is atrial fibrillation. The September 15, 2023 post — for PTA ( Pulse-Tap Artifact ). The March 17, 2023 post — for PTA.
109 
Journal of Cardiovascular Electrophysiology
FEBRUARY 10, 2025
ABSTRACT Background Early rhythm-control after atrial fibrillation (AF) incidence is associated with improved cardiovascular outcomes. Moreover, AF ablation provides more effective rhythm-control than antiarrhythmic drugs (AADs). The extent of adoption of contemporary trials and guidelines for the management of new onset AF is unknown.
40 
DAIC
MARCH 26, 2024
The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 Food and Drug Administration (FDA) in July 2023, a new leadless pacemaker system placed in both chambers of the heart and using a novel communication technology is now offering a more minimally invasive option for patients. Approved by the U.S.
105 
Journal of Cardiovascular Electrophysiology
JANUARY 13, 2025
ABSTRACT Background Atrial fibrillation (AF) is the most common arrhythmia worldwide. Methods We included adult patients who had an index admission with AF to Latakia's tertiary center between July 2021 and November 2023. Patients were monitored for readmission for 6 months after index discharge.
DAIC
DECEMBER 26, 2023
milla1cf Tue, 12/26/2023 - 21:19 December 26, 2023 — Pulse Biosciences, Inc. , The catheter is designed to deliver a fast, transmural and fully circumferential ablation in a single energy delivery.
59 Journal of Cardiovascular Electrophysiology
NOVEMBER 17, 2023
Results Between December 2022 and February 2023, 20 patients (67 ± 10 years, 53% male) undergoing PFA (Farapulse, Boston Scientific) for atrial fibrillation (AF) were studied and compared with a previous cohort of 57 patients who underwent thermic PVI (CB: n = 33; RF: n = 24).
Circulation: Arrhythmia and Electrophysiology
OCTOBER 25, 2023
Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012191, November 1, 2023. Atrioventricular AP (true AP) were distinguished from fasciculoventricular fibers (FVF) using standard invasive electrophysiology study criteria. Preexcitation was exclusively FVF mediated in 8 (36%) patients.
Journal of Cardiovascular Electrophysiology
MARCH 11, 2024
Abstract Introduction Cather ablation (CA) is a well-recognized treatment alternative for atrial fibrillation (AF) patients despite more than 20% ablation-treated patients suffering from AF recurrence.
Journal of Cardiovascular Electrophysiology
FEBRUARY 13, 2024
Abstract Introduction Heart failure (HF) and atrial fibrillation (AF) frequently co-exist. A systematic search of PubMed, EMBASE, and Cochrane Library databases until February 28, 2023. Aggregate data comparing the risk profile of AF between these three HF categories are lacking.
Heart 2023 Conference
APRIL 25, 2022
KEY POINTS Ambulatory ECG tracking is generally used to correlate signs with arrhythmia, verify occult atrial fibrillation, and determine the efficacy of antiarrhythmic therapy. Ambulatory electrocardiography (ECG) started out in 1949 while Norman “Jeff” Holter evolved a display that might wirelessly transmit electrophysiologic data.1
52 
DAIC
FEBRUARY 29, 2024
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
103 Journal of Cardiovascular Electrophysiology
APRIL 10, 2025
Methods The TriNetX database (Jan 2015June 2023) was queried to include adults receiving their first single-chamber ventricular pacemaker for heart block, bradycardia, sick sinus syndrome, atrial fibrillation, or syncope, excluding those with prior pacemakers, heart failure or enrolled for research settings.
40 
DAIC
DECEMBER 19, 2023
Image courtesy: Peerbridge Health christine.book Tue, 12/19/2023 - 10:22 December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective, feasibility clinical trial, resulting in a statistically significant 91.2%
DAIC
FEBRUARY 14, 2025
In particular, the study showed superiority in the percentage of patients that achieved freedom from atrial fibrillation (AF) with or without anti-arrhythmic drugs at 12 months after a tailored cardiac ablation guided by AI in combination with PVI when compared to PVI alone. tim.hodson Fri, 02/14/2025 - 09:57 Feb. adult population.
DAIC
JULY 24, 2024
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.
DAIC
DECEMBER 14, 2023
It's a major step towards fulfilling our vision of providing disruptive electrophysiology solutions for patients," said Rebecca Seidel, SVP and President of the Cardiac Ablation Solutions business, which is part of the Cardiovascular Portfolio. November 2023. Commercialization of the PulseSelect PFA system will start in early 2024.
DAIC
JUNE 19, 2024
While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.
105 
Journal of Cardiovascular Electrophysiology
NOVEMBER 5, 2024
Methods We studied consecutive patients undergoing EP procedures at our institution between March and December 2023. Procedures were most commonly for atrial fibrillation (52.4%), atrial flutter (10.9%), and atrioventricular nodal re-entrant tachycardia (10.1%). 01; minor: MC 16.5%, Fo8 HT 12.0%, Fo8 MOD 7.4%, p =.002).
DAIC
FEBRUARY 12, 2024
“Therefore, we have made the decision to offer only DX technology for new patients needing a single-chamber ICD, providing equivalent therapies along with additional atrial monitoring data, as recommended by current guidelines.” Journal of Cardiovascular Electrophysiology, Volume 30, Issue 10, October 2019, Pages 1994–2001.
64 
DAIC
MARCH 5, 2024
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). Atrial Fibrillation. Circulation.
59 
All About Cardiovascular System and Disorders
OCTOBER 26, 2023
Brugada Syndrome: Diagnosis and Risk Stratification Hello friends, this is the modified version of my talk at Indian Heart Rhythm Society Conference, New Delhi, 2023, on Brugada Syndrome. If three or more extra stimuli are needed for induction of ventricular fibrillation, the importance comes down further. mV or R/q ≥ 0.75.
Cardiometabolic Health Congress
DECEMBER 7, 2023
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrial fibrillation (AF). link] ACC/AHA Release Updated Atrial Fibrillation Guidelines for 2023. Sources: Joglar, J, Chung, M. J Am Coll Cardiol.
Society of Thoracic Surgeons - Research
APRIL 20, 2023
Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.
52 
Society of Thoracic Surgeons - Research
APRIL 20, 2023
Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.
52 
Journal of the American Heart Association
MARCH 21, 2025
BackgroundLowvoltage areas in the left atrium predict atrial fibrillation recurrence after catheter ablation and are associated with adverse outcomes like death, heart failure, and stroke. We included 108 patients with atrial fibrillation scheduled for catheter ablation.
Dr. S. Venkatesan MD
JANUARY 28, 2025
For right or wrong reasons, the world of electrophysiology has pushed us into a belief system that, if it is AF, the culprit must be pulmonary veins. If we look at the above map,RA prevails over LA convincigly in termes of focal atrial tachycardia. Role of non-pulmonary vein triggers in persistent atrial fibrillation.
Journal of Cardiovascular Electrophysiology
APRIL 18, 2025
High-frequency low-tidal volume (HFLTV) ventilation is a safe and cost-effective strategy that improves the efficiency and efficacy of radiofrequency catheter ablation (RFCA) for paroxysmal and persistent atrial fibrillation (PAF/PeAF). The primary outcome was freedom from all-atrial arrhythmias at 12-month follow-up.
Journal of Cardiovascular Electrophysiology
MARCH 24, 2025
ABSTRACT Background Different ablation strategies have been developed for persistent atrial fibrillation (PeAF), but early management is still controversial. Methods and Results Between January 2020 and December 2023, 118 PeAF patients were selected for first intent Marshall plan ablation (MPA).
DAIC
OCTOBER 30, 2024
The PulseSelect Pulsed Field Ablation System, which was FDA approved in December 2023, offers physicians a safe, single-shot solution for pulmonary vein isolation (PVI) while the Affera Sphere-9 catheter enables physician treatment flexibility with its wide area focal design and 9mm lattice tip that can used with an 8.5Fr sheath.
52
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content